Becton Dickinson to validate lot "partialling" of plated media in response to FDA warning letter.
This article was originally published in The Gray Sheet
BECTON DICKINSON LOT "PARTIALLING" OF PLATED MEDIA WILL BE VALIDATED, the company says in a Jan. 13 response to a Dec. 16 FDA warning letter. The process of "partialling" the in vitro diagnostics is intended to remove only portions of lots presumed contaminated prior to distribution.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.